The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study

Ticagrelor (TICA) and clopidogrel (CLP) are extensively used antiplatelet drugs that act by antagonizing the P2Y12 receptors that are found on platelets in addition to bone cells. Aim. The purpose of this study was to investigate the effect of clopidogrel and ticagrelor on stem cells osteogenic diff...

Full description

Saved in:
Bibliographic Details
Main Authors: Sally S. Mohamed, Hala F. Zaki, Shereen N. Raafat
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Advances in Pharmacological and Pharmaceutical Sciences
Online Access:http://dx.doi.org/10.1155/2024/2990670
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559600811900928
author Sally S. Mohamed
Hala F. Zaki
Shereen N. Raafat
author_facet Sally S. Mohamed
Hala F. Zaki
Shereen N. Raafat
author_sort Sally S. Mohamed
collection DOAJ
description Ticagrelor (TICA) and clopidogrel (CLP) are extensively used antiplatelet drugs that act by antagonizing the P2Y12 receptors that are found on platelets in addition to bone cells. Aim. The purpose of this study was to investigate the effect of clopidogrel and ticagrelor on stem cells osteogenic differentiation in vitro. Methods. Human adipose-derived mesenchymal stem cells (hAd-MSCs) were divided into (1) control group, (2) osteogenic group (osteo group), (3) clopidogrel group (CLP group), and (4) ticagrelor group (TICA group). The osteogenic differentiation potential was determined by mineralization nodule formation using Alizarin Red S staining, measuring ALP enzyme activity by alkaline phosphatase assay. Quantitative determination for osteogenic markers included osteocalcin (OC); runt-related transcription factor 2 (RUNX2) performed using western blot; osteoprotegerin (OPG) using enzyme-linked immunosorbent assay (ELISA) and inflammatory markers; and tumor necrosis factor (TNF-α) and interleukin-6 (IL-6) measured using real-time polymerase chain reaction quantitative (RT-PCR) and ELISA. Results. In comparison to all study groups, the TICA group showed significant increase in the mineralized extracellular matrix, ALP enzyme activity, and bone markers expression as RUNX2 (P<0.0001), OC, and OPG (P<0.05). The expression of IL-6 and TNF-α was determined by RT-qPCR and ELISA techniques. TICA and CLP significantly decreased both markers compared to the control group. The TICA group showed statistically significant lower levels of both markers (P<0.0001) than the CLP and control groups via the ELISA technique. Conclusion. TICA may possess a positive effect on hAd-MSCs osteogenic differentiation compared to CLP.
format Article
id doaj-art-058e689b4c854a33ba1596f1e5c2bfe0
institution Kabale University
issn 2633-4690
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological and Pharmaceutical Sciences
spelling doaj-art-058e689b4c854a33ba1596f1e5c2bfe02025-02-03T01:29:32ZengWileyAdvances in Pharmacological and Pharmaceutical Sciences2633-46902024-01-01202410.1155/2024/2990670The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative StudySally S. Mohamed0Hala F. Zaki1Shereen N. Raafat2Pharmacology DepartmentDepartment of Pharmacology and ToxicologyPharmacology DepartmentTicagrelor (TICA) and clopidogrel (CLP) are extensively used antiplatelet drugs that act by antagonizing the P2Y12 receptors that are found on platelets in addition to bone cells. Aim. The purpose of this study was to investigate the effect of clopidogrel and ticagrelor on stem cells osteogenic differentiation in vitro. Methods. Human adipose-derived mesenchymal stem cells (hAd-MSCs) were divided into (1) control group, (2) osteogenic group (osteo group), (3) clopidogrel group (CLP group), and (4) ticagrelor group (TICA group). The osteogenic differentiation potential was determined by mineralization nodule formation using Alizarin Red S staining, measuring ALP enzyme activity by alkaline phosphatase assay. Quantitative determination for osteogenic markers included osteocalcin (OC); runt-related transcription factor 2 (RUNX2) performed using western blot; osteoprotegerin (OPG) using enzyme-linked immunosorbent assay (ELISA) and inflammatory markers; and tumor necrosis factor (TNF-α) and interleukin-6 (IL-6) measured using real-time polymerase chain reaction quantitative (RT-PCR) and ELISA. Results. In comparison to all study groups, the TICA group showed significant increase in the mineralized extracellular matrix, ALP enzyme activity, and bone markers expression as RUNX2 (P<0.0001), OC, and OPG (P<0.05). The expression of IL-6 and TNF-α was determined by RT-qPCR and ELISA techniques. TICA and CLP significantly decreased both markers compared to the control group. The TICA group showed statistically significant lower levels of both markers (P<0.0001) than the CLP and control groups via the ELISA technique. Conclusion. TICA may possess a positive effect on hAd-MSCs osteogenic differentiation compared to CLP.http://dx.doi.org/10.1155/2024/2990670
spellingShingle Sally S. Mohamed
Hala F. Zaki
Shereen N. Raafat
The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study
Advances in Pharmacological and Pharmaceutical Sciences
title The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study
title_full The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study
title_fullStr The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study
title_full_unstemmed The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study
title_short The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study
title_sort effect of clopidogrel and ticagrelor on human adipose mesenchymal stem cell osteogenic differentiation potential in vitro comparative study
url http://dx.doi.org/10.1155/2024/2990670
work_keys_str_mv AT sallysmohamed theeffectofclopidogrelandticagreloronhumanadiposemesenchymalstemcellosteogenicdifferentiationpotentialinvitrocomparativestudy
AT halafzaki theeffectofclopidogrelandticagreloronhumanadiposemesenchymalstemcellosteogenicdifferentiationpotentialinvitrocomparativestudy
AT shereennraafat theeffectofclopidogrelandticagreloronhumanadiposemesenchymalstemcellosteogenicdifferentiationpotentialinvitrocomparativestudy
AT sallysmohamed effectofclopidogrelandticagreloronhumanadiposemesenchymalstemcellosteogenicdifferentiationpotentialinvitrocomparativestudy
AT halafzaki effectofclopidogrelandticagreloronhumanadiposemesenchymalstemcellosteogenicdifferentiationpotentialinvitrocomparativestudy
AT shereennraafat effectofclopidogrelandticagreloronhumanadiposemesenchymalstemcellosteogenicdifferentiationpotentialinvitrocomparativestudy